Vegetative dysfunction syndrome: Diagnosis and treatment

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

As an official diagnosis for autonomic disorders, ICD-10 uses code G90 – «disorders of the autonomic nervous system». According to a survey of 206 neurologists and therapists in Russia, 97% of respondents use the diagnosis «vegetative dysfunction syndrome» (VDS) in their practice. Among its symptoms are asthenia, functional dizziness, breathing disorders, paroxysmal conditions, etc. VDS always develops against the background of anxiety and/or depressive disorders, and therefore the entire range of psychotropic drugs is used in outpatient practice – antidepressants, tranquilizers, antipsychotics. However, the patients are not always ready to accept psychotropic therapy, so there is often a need to search for alternative treatment strategies for VDS, including the use of herbal drugs and nootropics. Complex therapy with Picamilon and Corvalol Phyto/Phytocomfort makes it possible to level out, and in some cases stabilize, the manifestations of autonomic dysfunction by its impact on the pathogenesis of VDS.

Full Text

Restricted Access

About the authors

Olga V. Kotova

Peoples’ Friendship University of Russia; International Society «Stress under Control»

Author for correspondence.
Email: ol_kotova@mail.ru
ORCID iD: 0000-0002-3908-0381

PhD in Medical Sciences, Neurologist, Psychiatrist, Psychotherapist, Associate Professor of the Department of Psychiatry, Psychotherapy and Psychosomatic Pathology of the Faculty of Continuing Medical Education, Peoples’ Friendship University of Russia; Vice President of the International Society «Stress under Control»

Russian Federation, Moscow; Moscow

Anton A. Belyaev

N.V. Sklifosovsky Research Institute of Emergency Medicine of the Department of Healthcare of Moscow

Email: ol_kotova@mail.ru
ORCID iD: 0000-0002-7186-870X

Neurologist, Junior Researcher at the Department of Emergency Vascular Surgery

Russian Federation, Moscow

Elena S. Akarachkova

International Society «Stress under Control»

Email: ol_kotova@mail.ru
ORCID iD: 0000-0002-7629-3773

MD, Neurologist, President of the International Society «Stress under Control», Deputy Chief Physician of the Rehaline Rehabilitation Center

Russian Federation, Moscow

Irina V. Borodulina

Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia

Email: ol_kotova@mail.ru
ORCID iD: 0000-0001-7526-1553

PhD in Medical Sciences, Neurologist

Russian Federation, Moscow

Svetlana V. Pavlova

Children’s City Clinic No. 39 of the Department of Healthcare of Moscow

Email: ol_kotova@mail.ru

PhD in Medical Sciences, Chief Physician 

Russian Federation, Moscow

References

  1. Котова О.В., Акарачкова Е.С., Беляев А.А. Психовегетативный синдром: трудности диагностики и эффективного лечения. Медицинский совет. 2018; (21): 50–55. [Kotova О.V., Akarachkova E.S., Belyaev A.A. Psychovegetative syndrome: Challenges in diagnosis and effective treatment. Meditsinskiy sovet = Medical Council. 2018; (21): 50–55 (In Russ.)]. https://dx.doi.org/10.21518/2079-701X-2018-21-50-55. EDN: YTUVDN.
  2. Орлова И., Орлов Ф., Голенков А. Психовегетативные синдромы у неврологических больных. Врач. 2019; 30(12): 18–21. [Orlova I., Orlov F., Golenkov A. Psychoautonomic syndromes in neurological patients. Vrach = The Doctor. 2019; 30(12): 18–21 (In Russ.)]. https://dx.doi.org/10.29296/25877305-2019-12-05. EDN: BNYUNI.
  3. Акарачкова Е.С. К вопросу диагностики и лечения психовегетативных расстройств в общесоматической практике. Лечащий врач. 2010; (10): 60. [Akarachkova E.S. Revisiting the diagnosis and treatment of psycho-vegetative disorders in general practice. Lechaschiy vrach = Attending Physician. 2010; (10): 60 (In Russ.)]. EDN: SGGGTJ.
  4. Rief W., Martin A. How to use the new dsm-5 somatic symptom disorder diagnosis in research and practice: A critical evaluation and a proposal for modifications. Annu Rev Clin Psychol. 2014; 10: 339–67. https://dx.doi.org/10.1146/annurev-clinpsy-032813-153745.
  5. Rice A.S., Smith B.H., Blyth F.M. Pain and the global burden of disease. Pain. 2016; 157(4): 791–96. https://dx.doi.org/10.1097/j.pain.0000000000000454.
  6. Психиатрические аспекты неврологических заболеваний. Подходы к ведению больных. Под ред. К.Г. Ликетсоса, П.В. Рэбинса, Дж.Р. Липси, Ф.Р. Слэвни. М.: МЕДпресс-информ. 2017; 328 c. [Psychiatric aspects of neurological diseases. Approaches to the management of patients. Ed. by Lyketsos K.G., Rabins P.V., Lipsi J.R., Slevi F.R. Moscow: MEDpress-inform. 2017; 328 pp. (In Russ.)]. ISBN: 978-5-00030-393-1.
  7. Вегетативные расстройства: клиника, лечение, диагностика. Руководство для врачей. Под ред. А.М. Вейна, Голубева В.Л. М.: Медицинское информационное агентство. 2010; 637 с. [Vegetative disorders: Clinic, treatment, diagnosis. A guide for physicians. Ed. by Wayne A.M., Golubev V.L. Moscow: Medical News Agency. 2010; 637 pp. (In Russ.)]. ISBN: 978-5-89481-808-5. EDN: QLWDYN.
  8. Котова О.В. Возможности терапии психовегетативного синдрома. Трудный пациент. 2011; 9(12): 24–27. [Kotova O.V. Options for treatment of psycho-vegetative syndrome. Trudny patsient = Difficult Patient. 2011; 9(12): 24–27 (In Russ.)]. EDN: PBIGPJ.
  9. Kroenke K. Patients presenting with somatic complaints: Epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res. 2003; 12(1): 34–43. https://dx.doi.org/10.1002/mpr.140.
  10. Aiarzaguena J.M., Grandes G., Salazar A. et al. The diagnostic challenges presented by patients with medically unexplained symptoms in general practice. Scand J Prim Health Care. 2008; 26(2): 99–105. https://dx.doi.org/10.1080/02813430802048662.
  11. Liao S.C., Ma H.M., Lin Y.L., Huang W.L. Functioning and quality of life in patients with somatic symptom disorder: The association with comorbid depression. Compr Psychiatry. 2019; 90: 88–94. https://dx.doi.org/10.1016/j.comppsych.2019.02.004.
  12. Chew-Graham C.A., Heyland S., Kingstone T. et al. Medically unexplained symptoms: Continuing challenges for primary care. Br J Gen Pract. 2017; 67(656): 106–7. https://dx.doi.org/10.3399/bjgp17X689473.
  13. Walsemann K.M., Gee G.C., Ro A. Educational attainment in the context of social inequality: New directions for research on education and health. Am Behav Sci. 2013; 57(8): 1082–104. https://dx.doi.org/10.1177/0002764213487346.
  14. Evangelidou S., NeMoyer A., Cruz-Gonzalez M. et al. Racial/ethnic differences in general physical symptoms and medically unexplained physical symptoms: Investigating the role of education. Cultur Divers Ethnic Minor Psychol. 2020; 26(4): 557–69. https://dx.doi.org/10.1037/cdp0000319.
  15. Escobar J.I., Cook B., Chen C.N. et al. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J Psychosom Res. 2010; 69(1): 1–8. https://dx.doi.org/10.1016/j.jpsychores.2010.01.001.
  16. Kisely S., Simon G. An international study comparing the effect of medically explained and unexplained somatic symptoms on psychosocial outcome. J Psychosom Res. 2006; 60(2): 125–30. https://dx.doi.org/10.1016/j.jpsychores.2005.06.064.
  17. van Eck van der Sluijs J., Ten Have M., Rijnders C. et al. Medically unexplained and explained physical symptoms in the general population: Association with prevalent and incident mental disorders. PLoS One. 2015; 10(4): e0123274. https://dx.doi.org/10.1371/journal.pone.0123274.
  18. De Waal M.W.M., Arnold I.A., Eekhof J.A., Van Hemert A.M. Somatoform disorders in general practice: Prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry. 2004; 184: 470–76. https://dx.doi.org/10.1192/bjp.184.6.470.
  19. Drayer R.A., Mulsant B.H., Lenze E.J. et al. Somatic symptoms of depression in elderly patients with medical comorbidities. Int J Geriatr Psychiatry. 2005; 20(10): 973–82. https://dx.doi.org/10.1002/gps.1389.
  20. Kirmayer L.J., Young A. Culture and context in the evolutionary concept of mental disorder. J Abnorm Psychol. 1999; 108(3): 446–52. https://dx.doi.org/10.1037//0021-843x.108.3.446.
  21. Whiteford H.A., Degenhardt L., Rehm J. et al.. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382(9904): 1575–86. https://dx.doi.org/10.1016/S0140-6736(13)61611-6.
  22. Zuberi A., Waqas A., Naveed S. et al. Prevalence of mental disorders in the WHO Eastern Mediterranean region: A systematic review and meta-analysis. Front Psychiatry. 2021; 12: 665019. https://dx.doi.org/10.3389/fpsyt.2021.665019.
  23. Акарачкова Е.С., Котова О.В., Вершинина С.В., Рябоконь И.В. Стресс и расстройства адаптации. Лечащий врач. 2014; (6): 61. [Akarachkova E.S., Kotova O.V., Vershinina S.V., Ryabokon I.V. Stress and adjustment disorders. Lechaschiy vrach = Attending Physician. 2014; (6): 61 (In Russ.)]. EDN: SFAZTH.
  24. Котова О.В., Медведев В.Э., Акарачкова Е.С., Беляев А.А. Ковид-19 и стресс-связанные расстройства. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021; 121(5–2): 122–128. [Kotova O.V., Medvedev V.E., Akarachkova E.S., Belyaev A.A. COVID-19 and stress-related disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2021; 121(5–2): 122–128 (In Russ.)]. https://dx.doi.org/10.17116/jnevro2021121052122. EDN: FMGHUN.
  25. Акарачкова Е.С., Климов Л.В., Котова О.В. 21 век: от пандемии COVID-19 к новым психосоциальным стрессам. Клиническое руководство. М.: Издательство «Перо». 2022; 34 с. [Akarachkova E.S., Klimov L.V., Kotova O.V. 21st century: From COVID-19 pandemic to new psychosocial stress clinical guidelines. Clinical guide. Moscow: Pero Publishing House. 2022; 34 pp. (In Russ.)]. ISBN: 978-5-00204-108-4. EDN: EEUPXE.
  26. Junghaenel D.U., Christodoulou C., Lai J.-S., Stone A.A. Demographic correlates of fatigue in the US general population: results from the patient-reported outcomes measurement information system (PROMIS) initiative. J Psychosom Res. 2011; 71(3): 117–23. https://dx.doi.org/10.1016/j.jpsychores.2011.04.007.
  27. Kuratsune H. Overview of chronic fatigue syndrome focusing around prevalence and diagnostic criteria. Nihon Rinsho. 2007; 65(6): 983–90.
  28. Benarroch E.E. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc. 2012; 87(12): 1214–25. https://dx.doi.org/10.1016/j.mayocp.2012.08.013.
  29. Reynolds G.K., Lewis D.P., Richardson A.M., Lidbury B.A. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort. J Intern Med. 2014; 275(4): 409–17. https://dx.doi.org/10.1111/joim.12161.
  30. Matsuo K., Harada K., Fujita Y. et al. Distinctive neuroanatomical substrates for depression in bipolar disorder versus major depressive disorder. Cereb Cortex. 2019; 29(1): 202–14. https://dx.doi.org/10.1093/cercor/bhx319.
  31. Staab J.P., Eckhardt-Henn A., Horii A. et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the classification of vestibular disorders of the Barany society. J Vestib Res. 2017; 27(4): 191–208. https://dx.doi.org/10.3233/VES-170622.
  32. Hashimoto K., Takeuchi T., Ueno T. et al. Examination of the effectiveness of antidepressants for functional dizziness with depressive mood by randomized controlled trial – A pilot study. Jpn J Psychosom Med. 2021; 61: 364–70.
  33. Yamamoto S., Ouchi Y., Onoe H. et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport. 2004; 15(17): 2571–74. https://dx.doi.org/10.1097/00001756-200412030-00002.
  34. Воробьева О.В. Тревожные расстройства в неврологической практике. РМЖ. 2007; 15(24): 1820. [Vorobyova O.V. Anxiety disorders in neurological practice. Russkiy meditsinskiy zhurnal = Russian Medical Journal 2007; 15(24): 1820 (In Russ.)].
  35. Котова О.В., Максимова Л.Н. Пациент с психовегетативным синдромом: помогает врач общей практики. Фарматека. 2012; (19): 36–41. [Kotova O.V., Maksimova L.N. Patient with psycho-vegetative syndrome: general practitioner helping. Farmateka. 2012; (19): 36–41 (In Russ.)]. EDN: PKEVLX.
  36. Shikov A.N., Pozharitskaya O.N., Makarov V.G. et al. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytother Res. 2011; 25(4): 540–43. https://dx.doi.org/10.1002/ptr.3292.
  37. Cases J., Ibarra A., Feuillere N. et al. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011; 4(3): 211–18. https://dx.doi.org/10.1007/s12349-010-0045-4.
  38. Гультяева В.В., Зинченко М.И., Урюмцев Д.Ю. с соавт. Физическая нагрузка при лечении депрессии. Физиологические механизмы. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019; 119(7): 112–119. [Gultyaeva V.V., Zinchenko M.I., Uryumtsev D.Yu. et al. Exercise for depression treatment. Physiological mechanisms. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2019; 119(7): 112–119 (In Russ.)]. https://dx.doi.org/10.17116/jnevro2019119071112. EDN: AWEYKI.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies